Genistein treatment reduces arterial contractions by inhibiting tyrosine kinases in ovariectomized hypertensive rats

European Journal of Pharmacology

Volumn 452, Issue 1, 2002, Pages 87-96

  Nevala, Riikka ^a   Lassila, Markus ^a   Finckenberg, Piet ^a   Paukku, Kirsi ^b   Korpela, Riitta ^a   Vapaatalo, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Estradiol 17 ; Genistein; Renal artery; SHR (Spontaneously hypertensive rat); Tyrosine phosphorylation

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; DIMETHYL SULFOXIDE; ENDOTHELIN 1; ESTRADIOL; GENISTEIN; META TYROSINE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE; PROTEIN TYROSINE KINASE; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ELECTROLYTE EXCRETION; ENZYME INHIBITION; ESTROGEN ACTIVITY; FEMALE; FOOD INTAKE; HYPERTENSION; KIDNEY MASS; NONHUMAN; OVARIECTOMY; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; RENAL ARTERY; UTERUS WEIGHT; VASODILATATION;

ANIMALS; ARTERIES; BLOOD PRESSURE; BODY WEIGHT; CREATININE; EATING; ELECTROLYTES; ENZYME INHIBITORS; ESTRADIOL; FEMALE; GENISTEIN; HYPERTENSION; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; OVARIECTOMY; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED SHR; RENAL CIRCULATION; TYROSINE; UTERUS;

EID: 0037183778     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02270-7     Document Type: Article

References (55)

1. Abebe W., Agrawal D.K. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J. Cardiovasc. Pharmacol. 26:1995;153-159.
2. Adlercreutz H., Goldin B., Gorbacetylcholine S., Höckerstedt K., Watanabe S., Hämäläinen E., Markkanen M., Mäkelä T., Wähälä K., Hase T., Fotsis T. Soybean phytoestrogen intake and cancer risk. J. Nutr. 125:1995;757-770.
3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem. 262:1987;5592-5595.
4. Bartels H., Bohmer M., Heierli C. Serum creatinine determination without protein precipitation. Clin. Chim. Acta. 37:1972;193-197.
5. Berk B. Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J. Am. Soc. Nephrol. 10:1999;62-68.
6. Berk B., Corson M. Angiotensin II signal transduction in vascular smooth muscle. Circ. Res. 80:1997;607-616.
7. Betts L.C., Kozlowski R.Z. Electrophysiological effects of endothelin-1 and their relationship to contraction in rat renal arterial smooth muscle. Br. J. Pharmacol. 130:2000;787-796.
8. Brosnihan B., Li P., Ganten D., Ferrario C. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am. J. Physiol. 273:1997;1908-1915.
9. Cali J., Bowers G. Jr., Young D. A reference method for the determination of total calcium in serum. Clin. Chem. 19:1973;1208-1213.
10. Chen H., Bischoff A., Schafers R.F., Wambach G., Philipp T., Michel M.C. Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y. J. Auton. Pharmacol. 17:1997;137-146.
11. Cheng D., Gruetter C. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur. J. Pharmacol. 215:1992;171-176.
12. David F., Carvalho M., Cobra A., Nigro D., Fortes Z., Reboucas N., Tostes R. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension. 38:2001;692-696.
13. Di Salvo J., Nelson S.R., Kaplan N. Protein tyrosine phosphorylation in smooth muscle, A potential coupling mechanism between receptor activation and intracellular calcium. P.S.E.B.M. 214:1997;285-301.
14. Duarte J., Ocete M., Pérez-Vizcaino F., Zarzuelo A., Tamargo J. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase. Eur. J. Pharmacol. 338:1997;25-33.
15. Eldridge A., Kwolek W. Soybean isoflavones, effect of environment and variety of composition. J. Agric. Food Chem. 31:1983;394-396.
16. Garcha R., Sever P., Hughes A. Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries. Br. J. Pharmacol. 134:2001;188-196.
17. Giménez I., Martinez R., Lou M., Mayoral J., Garau R., Alda J. Saliuretic action of genistein in the isolated perfused rat kidney. Hypertension. 31:1998;706-711.
18. Gisclard V., Miller V., Vanhoutte P. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244:1987;19-22.
19. Gross G.J., Gharaibeh M.N. Evidence for the site of action of glycerol trinitrate and diltiazem in inhibiting vasoconstrictor responses to norepinephrine in isolated renal arteries. Pharmacology. 32:1986;1-10.
20. Hoffman A., Grossman E., Ohman K.P., Marks E., Keiser H.R. The initial vasodilation and the later vasoconstriction of endothelin-1 are selective to specific vascular beds. Am. J. Hypertens. 3:1990;789-791.
21. Huang A., Sun D., Kaley G., Koller A. Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension. 29:1997;1351-1356.
22. Huang A., Sun D., Kaley G., Koller A. Estrogens preserve regulation of shear stress by nitric oxide in arterioles of female hypertensive rats. Hypertension. 31:1998;309-314.
23. Huang A., Sun D., Koller A., Kaley G. 17β-Estradiol restores endothelial nitric oxide release to shear in arterioles of male hypertensive rats. Circulation. 101:2000;94-100.
24. Iafrati M.D., Karas R.H., Aronovitz M., Kim S., Sullivan T.R. Jr., Lubahn D.B., O'Donnell T.F. Jr., Korach K.S., Mendelsohn M.E. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3:1997;545-548.
25. Jiang C., Sarrel P., Lindsay D., Poole-Wilson P., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-estradiol in vitro. Br. J. Pharmacol. 104:1991;1033-1037.
26. Jinsi A., Paradise J., Deth R.C. A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta. Eur. J. Pharmacol. 302:1996;183-190.
27. Kähönen M., Arvola P., Vapaatalo H., Pörsti I. Comparison of cumulative and noncumulative administration of vasoactive agents in arterial smooth muscle responses in vitro. Pharmacol. Toxicol. 73:1993;142-145.
28. Karas R.H., Hodgin J.B., Kwoun M., Krege J.H., Aronovitz M., Mackey W., Gustafsson J.A., Korach K.S., Smithies O., Mendelsohn M.E. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;15133-15136.
29. Koide M., Kawahara Y., Tsuda T., Ishida Y., Shii K., Yokoyama M. Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J. Hypertens. 10:1992;1173-1182.
30. Kuiper G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 38:1997;863-870.
31. Kuiper G., Lemmen J., Carlsson B., Corton J., Safe S., van der Saag P., van der Burg B., Gustafsson J. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4263.
32. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Laniyonu A., Saifeddine M., Yang S., Hollenberg M. Tyrosine kinase inhibitors and the contractile action of G-protein linked vascular agonist. Can. J. Physiol. Pharm. 72:1994;1075-1085.
34. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
35. Lydrup M., Nilsson B. Acute and long-term effects of 17beta-oestradiol on agonist-stimulated force in rat tail artery. Acta Physiol. Scand. 158:1996;253-259.
36. Masaki T. Possible role of endothelin in endothelial regulation of vascular tone. Annu. Rev. Pharmacol. Toxicol. 35:1995;235-255.
37. Nevala R., Korpela R., Vapaatalo H. Plant derived estrogens relax rat mesenteric artery in vitro. Life Sci. 63:1998;95-100.
38. Nevala R., Vaskonen T., Vehniäinen J., Korpela R., Vapaatalo H. Soy based diet attenuates the development of hypertension when compared to casein based diet in spontaneously hypertensive rat. Life Sci. 66:2000;115-124.
39. Nevala R., Paukku K., Korpela R., Vapaatalo H. Calcium sensitive K+ channel inhibitors antagonize genistein- and daidzein-induced arterial relaxation in vitro. Life. Sci. 69:2001;1407-1417.
40. Nickenig G., Baumer A., Grohe C., Kahlert S., Strehlow K., Rosenkranz S., Stablein A., Beckers F., Smits J., Daemen M., Vetter H., Bohm M. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 97:1998;2197-2201.
41. Okumura M., Imanishi M., Yamanaka S., Yamamoto K. Effects of endothelin on renal hemodynamics and renal function in anesthetized dogs. Am. J. Hypertens. 3:1990;632-634.
42. Pörsti I., Arvola P., Wuorela H., Ilkka M., Säynävälammi P., Huhtala H., Metsä-Ketelä T., Vapaatalo H. Effects of high calcium diet and deoxycorticosterone on vascular smooth muscle responses in spontaneously hypertensive rats. J. Hypertens. 8:1991;835-841.
43. Ravi J., Mantzoros C., Prabhu A., Ram J., Sowers J. In vitro relaxation of phenylephrine- and angiotensin II-contracted aortic rings by beta-estradiol. Am. J. Hypertens. 7:1994;1065-1069.
44. Register T., Adams M. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J. Steroid Biochem. Mol. Biol. 64:1998;187-191.
45. Roesch D., Tian Y., Zheng W., Shi M., Verbalis J., Sandberg K. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology. 141:2000;4629-4636.
46. Savineau J.P., Gonzalez G., De La Fuente P., Marthan R. Effect of modulators of tyrosine kinase activity on agonist-induced contraction in the rat pulmonary vascular smooth muscle. Pulm. Pharmacol. 9:1996;189-195.
47. Seo B., Emoto N., Choi D., Hwang J., Matsuo M., Kim E., Cheon I. Estrogen affects vascular tone differently according to vasoactive substances in ovariectomized Sprague-Dawley rat. Yonsei Med. 41:2000;49-55.
48. Shimada T., Shimamura K., Susano S. Effects of sodium vanadate on various types of vascular smooth muscle. Blood Vessels. 23:1986;113-124.
49. Squadrito F., Altavilla D., Squadrito G., Saitta A., Cucinotta D., Minutoli L., Deodato B., Ferlito M., Campo G., Bova A., Caputi A. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc. Res. 45:2000;454-462.
50. Tanaka M., Nakaya S., Watanabe M., Kumai T., Tateishi T., Kobayashi S. Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats. Jpn. J. Pharmacol. 73:1997;361-363.
51. Toma C., Jensen P., Prieto D., Hughes A., Mulvany M., Aalkjaer C. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries. Br. J. Pharmacol. 114:1995;1266-1272.
52. Williams S., Shackeltor D., Iams S., Mustafa S. Endothelium-dependent relaxation in estrogen treated spontaneously hypertensive rats. Eur. J. Pharmacol. 145:1988;205-207.
53. Wilson S.K. The effects of angiotensin II and norepinephrine on afferent arterioles in the rat. Kidney Int. 30:1986;895-905.
54. Zerrouk A., Auguet M., Dabire H., Brisac A., Safar M., Chabrier P. Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats. Eur. J. Pharmacol. 374:1999;49-58.
55. Zhang Y., Davidge S. Effect of estrogen replacement on vasoconstrictor responses in rat mesenteric artery. Hypertension. 34:1999;1117-1122.